SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 6.39 |
| Enterprise Value ($M) | 36.68 |
| Book Value ($M) | 7.10 |
| Book Value / Share | 4.30 |
| Price / Book | 0.90 |
| NCAV ($M) | -10.65 |
| NCAV / Share | -6.45 |
| Price / NCAV | -0.60 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.47 |
| Return on Assets (ROA) | -0.39 |
| Return on Equity (ROE) | -1.31 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.23 |
| Current Ratio | 0.23 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3.24 |
| Assets | 20.99 |
| Liabilities | 13.88 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.49 |
| Operating Income | -4.93 |
| Net Income | -7.90 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -4.97 |
| Cash from Investing | -0.10 |
| Cash from Financing | 7.64 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 13,564 | 48,645 | 27.88 | |
| 174,490 | 462,404 | 37.74 | |
| 6,668 | 21,928 | 30.41 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AIMD – Ainos, Inc. | AKAN – Akanda Corp. |
| AKBA – Akebia Therapeutics, Inc. | ALDX – Aldeyra Therapeutics, Inc. |
| ALGS – Aligos Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io